Terminated PHASE1 INTERVENTIONAL 3-arm NCT02750384

Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects

An Assessment of the Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects

Sponsor: AbbVie

Conditions Bioavailability Healthy Volunteers

Interventions DSM265 25% SDD powder for suspension DSM265 50% SDD granules

Updated 6 times since 2017 Last updated: Sep 13, 2016 Started: May 31, 2016 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor strategic decision based on preliminary results

Other terminated trials from AbbVie

See all terminations from AbbVie

Listed as NCT02750384, this PHASE1 trial focuses on Bioavailability and Healthy Volunteers and remains terminated or withdrawn. Sponsored by AbbVie, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE1

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AbbVie
Medicines for Malaria Venture

Data source: Medicines for Malaria Venture

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Grayslake, United States